Robert DeBusk

Summary

Affiliation: Stanford University
Country: USA

Publications

  1. ncbi Care management for low-risk patients with heart failure: a randomized, controlled trial
    Robert Frank DeBusk
    Stanford University School of Medicine, Stanford, California 94304 5735, USA
    Ann Intern Med 141:606-13. 2004
  2. ncbi Sexual activity in patients with angina
    Robert F Debusk
    Department of Medicine, Stanford University School of Medicine, Palo Alto, Calif 94304, USA
    JAMA 290:3129-32. 2003
  3. ncbi Efficacy and safety of sildenafil citrate in men with erectile dysfunction and stable coronary artery disease
    Robert F Debusk
    Stanford Cardiac Rehabilitation Program, Stanford University School of Medicine, Palo Alto, California 94304, USA
    Am J Cardiol 93:147-53. 2004
  4. ncbi Erectile dysfunction therapy in special populations and applications: coronary artery disease
    Robert F Debusk
    Stanford University School of Medicine, Stanford, California 94304 5735, USA
    Am J Cardiol 96:62M-66M. 2005

Research Grants

  1. New Strategies to Enhance Drug Adherence in Hypertension
    Robert DeBusk; Fiscal Year: 2003

Detail Information

Publications4

  1. ncbi Care management for low-risk patients with heart failure: a randomized, controlled trial
    Robert Frank DeBusk
    Stanford University School of Medicine, Stanford, California 94304 5735, USA
    Ann Intern Med 141:606-13. 2004
    ..Nurse care management programs for patients with chronic illness have been shown to be safe and effective...
  2. ncbi Sexual activity in patients with angina
    Robert F Debusk
    Department of Medicine, Stanford University School of Medicine, Palo Alto, Calif 94304, USA
    JAMA 290:3129-32. 2003
  3. ncbi Efficacy and safety of sildenafil citrate in men with erectile dysfunction and stable coronary artery disease
    Robert F Debusk
    Stanford Cardiac Rehabilitation Program, Stanford University School of Medicine, Palo Alto, California 94304, USA
    Am J Cardiol 93:147-53. 2004
    ..There were no serious drug-related cardiovascular effects. Thus, sildenafil is an effective and well-tolerated treatment for ED in men with CAD. Sildenafil was not associated with additional safety risks in this patient population...
  4. ncbi Erectile dysfunction therapy in special populations and applications: coronary artery disease
    Robert F Debusk
    Stanford University School of Medicine, Stanford, California 94304 5735, USA
    Am J Cardiol 96:62M-66M. 2005
    ..Progress in integrating PDE5 inhibitors into clinical practice will depend on the success with which patients with ED are evaluated and aggressively treated for endothelial cell dysfunction...

Research Grants3

  1. New Strategies to Enhance Drug Adherence in Hypertension
    Robert DeBusk; Fiscal Year: 2003
    ..Demonstration of the efficacy of nurse case management of hypertension in the proposed project may facilitate the dissemination of this approach to underserved populations throughout the U.S. ..